← Open Payments lookup

NPI 1043515034: Open Payments

NPI 1043515034. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,166 in 102 payments from 17 companies in 2025. Trend: 2023 $1,439 · 2024 $1,876 · 2025 $2,166

Food & beverage: $1,875Education: $291
CompanyPaymentsAmount
Janssen Biotech, Inc.18$444
ABBVIE INC.16$358
Organogenesis Inc.8$181
GENZYME CORPORATION6$181
LEO Pharma Inc.9$160
UCB, Inc.10$149
Lilly USA, LLC10$146
Regeneron Healthcare Solutions, Inc.2$121
Novartis Pharmaceuticals Corporation6$114
SUN PHARMACEUTICAL INDUSTRIES INC.4$74

Products named: TREMFYA, DUPIXENT, RINVOQ, Bimzelx, ADBRY, SKYRIZI, TALTZ, COSENTYX.